Molekule Group, Inc. Common Stock
MKUL
MKUL was delisted on the 12th of October, 2023.
17 hedge funds and large institutions have $32.3M invested in Molekule Group, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
83% more capital invested
Capital invested by funds: $17.7M → $32.3M (+$14.7M)
13% more funds holding
Funds holding: 15 → 17 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$6.13M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$83.5K |
| 3 |
SFG
SVB Financial Group
Dallas,
Texas
|
+$39.5K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.4K |
| 5 |
BlackRock
New York
|
+$6.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$18K |
MKUL Hedge Fund Activity: Q2 2023 in Review
17 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Molekule Group, Inc. Common Stock (MKUL) for Q2 2023, worth a combined $32.3M — up 83% from $17.7M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MKUL positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $6.13M. The largest seller was Millennium Management, exiting entirely with an estimated $18K sold.
- 17 institutional investors held Molekule Group, Inc. Common Stock (MKUL) as of Q2 2023, up from 15 in Q1 2023.
- Funds reported $32.3M of Molekule Group, Inc. Common Stock stock for Q2 2023, up 83% quarter-over-quarter.
- 3 funds opened new Molekule Group, Inc. Common Stock positions in Q2 2023 and 1 closed out, a net change of +2 holders.
- The largest Molekule Group, Inc. Common Stock buyer in Q2 2023 was Armistice Capital, an estimated $6.13M added.
- The largest Molekule Group, Inc. Common Stock seller in Q2 2023 was Millennium Management, an estimated $18K sold.
Based on aggregated 13F filings for Q2 2023.